A new UCLA-led study suggests that advanced genome editing technology could be used as a one-time treatment for the rare and deadly genetic disease CD3 delta severe combined immunodeficiency.
The condition, CD3 delta SCID, is caused by a mutation that prevents the production of the CD3 delta protein that is needed for the normal development of T cells
UCLA Study Cures Rare Immune Deficiency with Base Editing miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.